Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. The visible study content and links remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-11T16:22:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Lung cancer and the MedlinePlus Genetics related topics were removed from the page.
    Difference
    0.2%
    Check dated 2026-03-04T11:45:02.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added related topics Lung cancer and MedlinePlus Genetics to the related topics section.
    Difference
    0.2%
    Check dated 2026-02-25T08:41:36.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-status notice and related topic links (Lung cancer and MedlinePlus Genetics), and removed Revision: v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-11T05:13:23.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Site-wide notice about a lapse in government funding and operating status was added, and the page revision updated to v3.4.1. The core study content and criteria remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-04T03:58:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary) and updated UI text, standardizing labels such as 'Last Update Submitted that Met QC Criteria' and capitalization of 'No FEAR Act Data'. The revision/version banner now shows v3.4.0 (replacing v3.3.4); To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:55:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.